Skip to main content

Table 3 Total counts and proportions of peripheral blood cells in patients with and without TCFA

From: Comparison of circulating dendritic cell and monocyte subsets at different stages of atherosclerosis: insights from optical coherence tomography

 

Patients with TCFA (n = 20)

Patients without TCFA (n = 28)

p value

WBC, ×106/ml

6.88 ± 1.98

7.12 ± 1.98

0.690

PMN, % WBC

59.83 ± 9.45

61.33 ± 9.88

0.613

Lym, % WBC

32.75 ± 8.94

31.70 ± 9.87

0.717

PMN/Lym ratio

2.22 ± 1.69

2.29 ± 1.31

0.883

Mon, % WBC

5.83 ± 1.25

5.82 ± 1.41

0.989

mDC1s, % WBC

0.24 ± 0.05

0.21 ± 0.04

0.134

mDC2s, % WBC

1.08 × 10−2 ± 0.39 × 10−2

1.13 × 10−2 ± 0.44 × 10−2

0.664

mDCs, % WBC

0.25 ± 0.05

0.23 ± 0.05

0.151

pDCs, % WBC

0.15 ± 0.03

0.16 ± 0.03

0.285

mDC1s, ×104/ml

1.63 ± 0.61

1.57 ± 0.76

0.791

mDC2s, ×104/ml

0.08 ± 0.04

0.08 ± 0.05

0.605

mDCs, ×104/ml

1.71 ± 0.64

1.66 ± 0.79

0.825

pDCs, ×104/ml

1.07 ± 0.30

1.22 ± 0.41

0.173

Mon1, % monocytes

82.84 ± 6.17

82.02 ± 5.15

0.754

Mon2, % monocytes

11.96 ± 4.27

9.43 ± 5.15

0.035

Mon3, % monocytes

4.93 ± 3.22

8.43 ± 3.75

0.001

Mon1, ×105/ml

3.25 ± 0.96

3.52 ± 1.22

0.470

Mon2, ×104/ml

5.17 ± 1.92

3.53 ± 2.65

0.045

Mon3, ×104/ml

2.23 ± 1.44

3.66 ± 2.16

0.059

  1. Values are mean ± SD
  2. Abbreviations as Table 1 and Table 2. P-values of risk factors with significance are presented as italic form